UK Police Chiefs Call for Blocking Unsafe Social Media for Under16s Potential Regulatory Impact on Tech Giants
China Emerges as Primary Rival in Humanoid Robot Arms Race Musk Warns
Korea Post Diversifies Into AI Data Centres and Real Estate to Offset Mounting Mail Losses
Morrisons to Close 100 Stores Amid Rising Cost Pressures from Government Policies
Japan Hotel Rates Surge as US and European Tourists Offset Decline in Chinese Visitors
IHI Achieves Milestone with First Satellite Imagery from Observation Constellation
Arvinas ARVN Q1 2026 Earnings Narrower Loss Beats Estimates Amid Pipeline Progress
ClearPoint Neuro Inc CLPT Q1 2026 Earnings EPS Misses Estimates by 1478 Amid Operational Investment
MDA Space Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction
SKYT Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges
DRTS Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Company Continues Clinical Development
LAR Q1 2026 Earnings EPS Misses Estimates as Development Continues
CAAS Holds Near Support Amid Modest Gains
Baker Hughes BKR Edges Higher as Energy Sector Gains Momentum Key Levels in Focus
Strategy Inc MSTR Holds Steady Near 153 as Market Awaits Catalyst
Altisource Portfolio Solutions Warrants ASPSW Decline 22 Approach Critical 038 Support Level
Lifeward Ltd LFWD Edges Higher as Support Holds Resistance in Focus
Ferrari Luce EV Launch Sparks Controversy Shares Drop Nearly 8 on Design Criticism
BXSL Q1 2026 Earnings Slight EPS Beat Amid Stable Portfolio Performance
Kodiak AI Inc KDK Drops 655 as Shares Test Key Support at 677
IQST Q4 2025 Earnings Massive EPS Miss Highlights Ongoing Challenges
DOO Q1 2026 Earnings EPS Surprise of 796 Lifts Shares
Galiano Gold Inc GAU Q1 2026 Earnings EPS Misses Estimates but Stock Rises 273
Aktis Oncology AKTS Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline
BRID Q4 2001 Earnings EPS Misses Estimates Despite Stock Gain
LULU Q1 2026 Earnings EPS Beats Estimates Amid Modest Stock Uptick
CRVO Q1 2026 Earnings WiderthanExpected Loss as PreClinical Stage Company Reports No Revenue